Hem › Akut myeloid leukemi › Washington › Tacoma
Kliniska studier för Akut myeloid leukemi i Tacoma, WA
3 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Tacoma (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Providence Regional Cancer System-Lacey, Lacey · 23 mi bort
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekryterarFas 3
- Mary Bridge Children's Hospital and Health Center, Tacoma
- Madigan Army Medical Center, Tacoma
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- Mary Bridge Children's Hospital and Health Center, Tacoma
- Madigan Army Medical Center, Tacoma
Akut myeloid leukemi-studier i andra städer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andra studier i Tacoma
- Icke-småcellig lungcancer20 studier
- Bröstcancer18 studier
- Ulcerös kolit15 studier
- Multipelt myelom13 studier
- Prostatacancer11 studier
- Crohns sjukdom11 studier
- Kolorektal cancer9 studier
- Metastaserande cancer9 studier
- Melanom7 studier
- Äggstockscancer7 studier
- Magsäckscancer6 studier
- Esofageal cancer6 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.